Elevatus Welath Management Abbott Laboratories Transaction History
Elevatus Welath Management
- $176 Billion
- Q1 2025
A detailed history of Elevatus Welath Management transactions in Abbott Laboratories stock. As of the latest transaction made, Elevatus Welath Management holds 1,539 shares of ABT stock, worth $207,457. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,539Holding current value
$207,457% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,533Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.9 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.5 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$9.01 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.84 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...